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Atopy in HIV-infected children in Pretoria
R Masekela, T Moodley, N Mahlaba, D F Wittenberg, P Becker, O Kitchin, R J Green
Both atopic and HIV-related diseases are common in South 
Africa. Atopy is a genetic predisposition to form excessive 
immunoglobulin E (IgE), leading to a generalised and 
prolonged hypersensitivity to common environmental 
allergens – both inhaled and dietary. Atopic individuals 
manifest one or more of a group of diseases, including asthma, 
atopic eczema, allergic rhinitis, urticaria and gastrointestinal 
conditions, which tend to run in families.1 These have been 
shown to be associated with Th2 cytokines. Regulatory T cells 
via interleukin-10 (IL-10), a cytokine known to play a pivotal 
role in the expression of specific immune pathways in a specific 
individual, are involved.2
The burden of human immunodeficiency virus (HIV) 
infection in sub-Saharan Africa is high, with 230 000 children 
born annually to HIV-infected mothers in this region.1 The 
epidemic proportions of the disease make it essential for 
appropriate diagnosis and management of affected children. 
This disease has a significant impact on mortality, with HIV-
infected infant death rates as high as 130 - 390 per 1 000 live 
births.3 The availability of highly active antiretroviral treatment 
(HAART) in the last decade in the developed world has had a 
significant effect on the survival of patients infected with HIV.4 
Patients infected with HIV are therefore now demonstrating 
morbidity similar to other chronic conditions, including atopic 
conditions.
HIV is a retrovirus which, after gaining entry into the 
body, binds to a host of cells involved in innate and adaptive 
immunity.5 Resulting abnormalities affect both the cellular 
and humoral immune system. T-cell abnormalities that result 
in depletion of CD4 cells, as well as polyclonal activation 
of B cells with hyperglobulinaemia, are well known.6 This 
hyperglobulinaemia also affects IgE, with a marked elevation 
of this immunoglobulin. Adult studies have suggested an 
association between atopy and HIV;6,7 the evidence in children 
is scanty.
The switch from a Th1 to a Th2 cytokine profile has 
previously been shown to be a critical step in the progression 
of HIV infection to acquired immunodeficiency syndrome 
(AIDS) in adults.8,9 Even before depletion of CD4 cells, there 
is a qualitative defect in CD4 that results in loss of antigen 
and mitogen-induced interleukin-2 (IL-2) and interferon 
gamma (INF-γ) production. IL-2 and INF-γ are important 
cytokines in the Th1 pathway. A reduction in IL-2 results in 
a switch to interleukin-4 (IL-4) production, which is a critical 
step in the switch to a Th2-mediated response.8 IL-4 drives 
the development and expansion of Th2 cells and mediates 
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Introduction. The development or aggravation of a pre-existing 
atopic state in patients with human immunodeficiency virus 
(HIV) has not been thoroughly investigated in South Africa. 
HIV-infected adults have been shown to have a higher 
prevalence of atopy in some international studies, but this has 
not been documented in children.
Methods. A prospective convenience sample of 50 children 
aged between 3 months and 12 years attending the Tshwane 
District Hospital Paediatric HIV Clinic in Pretoria was 
recruited. Their personal and family histories of atopy, World 
Health Organization (WHO) HIV clinical staging and Centers 
for Disease Control (CDC) immunological staging with CD4 
counts were documented. An age- and sex-matched control 
group of 50 HIV-negative children was included. Skin prick 
tests (SPTs) to identify common aeroallergens were conducted 
on all patients.
Results. One hundred children were enrolled, with 50 in each 
group. Ten per cent of the HIV-infected patients compared 
with 16% of controls had positive SPTs to aeroallergens. A 
higher percentage of the HIV-infected patients had chronic 
rhinitis and eczema (60% and 68%, respectively). There 
was no relationship between CD4 count and  positive SPTs 
(p=0.61), mean log CD4 count and presence of reported 
asthma (p=0.71), and CD4 count and presence of reported 
dermatitis (p=0.84). The CD4 count was not statistically 
different between children with and without a family history 
of atopy (p=0.68).
Conclusion. It appears that the stage of HIV disease does not 
influence the development or expression of allergy. There is 
a high prevalence of dermatitis and chronic rhinitis in HIV-
infected children, probably not atopic in origin.
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downstream effector functions, such as B-cell activation, in 
particular increased major histocompatibility complex class II 
expression and isotype switching to IgE production.10 Although 
the exact mechanism is not well understood, a possible role 
of HIV antigen gp120 and HIV-1 trans-activating protein 
(Tat protein) is suspected. Gp120 is thought to act as a super-
antigen, stimulating the immune system with a bias toward 
Th2 cytokine production via release of IL-4 and interleukin-13 
(IL-13) from human F epsilon R-positive cells (FcεR1+ cells).11 
Tat protein may also act as a chemo-attractant for FcεR1+ cells 
and also upregulate chemokine receptor 3 (CCR3) expression.12
We aimed to study the association between atopy (sensitivity 
to environmental factors, i.e. allergy and clinical disease states) 
and HIV infection in children and the role of HIV infection on 
the development of allergy.
Methods
A prospective convenience sample of children aged 3 
months - 12 years attending the Tshwane District Hospital 
Paediatric HIV Clinic was obtained. Informed consent to take 
part in the study was one of the inclusion criteria. All HIV-
infected patients in the study were receiving antiretroviral 
therapy. Subjects for whom informed consent could not be 
obtained were excluded. Information regarding the children’s 
personal and family histories of atopy was recorded from 
information provided by parents/guardians. An overview of 
the children’s medical history and a general examination of 
their current state of well-being were conducted. The World 
Health Organization (WHO) HIV clinical staging, CD4 counts 
obtained by flow cytometric analysis, and evidence of atopy 
were also recorded.13 An age- and sex-matched control group of 
50 healthy HIV-negative children attending routine follow-up 
at the cardiology and neurology clinics of Pretoria Academic 
Hospital were included. Skin prick tests (SPTs) (Alk-Abello) 
for common aeroallergens were conducted on all patients with 
negative saline and on positive (histamine-dihydrochloride 
10mg/ml) controls. An induration of 3 mm or greater than 
the negative control was regarded as a positive result. The 
allergen extracts used were: Bermuda grass, five-grass mix, 
tree mix, dog hair dander, cat hair dander, standard mite 
(Dermatophagoides pteronyssinus), and cockroach (Blatana sp).
Diagnoses of asthma, allergic rhinitis and eczema were 
offered to respondents in the questionnaire but were neither 
investigated nor proven.
Statistical analysis
A Welch two-sample t-test with unequal variances was 
employed in the analysis of the CD4 count with regard to 
family history of atopy, dermatitis and asthma. A p-value of 
<0.05 was considered statistically significant.
Approval for the study was obtained from the Research 
Ethics Committee of the University of Pretoria. Informed 
consent was obtained from all parents or guardians of the 
patients. Assent was also obtained from all subjects >7 years 
old.
Results
A total of 100 children were enrolled, with half in the study 
arm and half in the control group. Forty-five (90%) of the 50 
HIV-infected children and 42 (84%) of the control group had 
a negative SPT to common aeroallergens (Tables I and II). 
There was no statistical difference between groups (p=0.95). 
The most common allergen identified was D. pteronyssinus 
in both groups, with 3 of the 5 HIV-infected patients being 
monosensitive to house dust mite (Fig. 1).
Twelve (24%) of the HIV-infected children tested had a 
positive family history of atopy, while only 2 of them had a 
reactive SPT. Eleven (22%) HIV-infected children had been 
diagnosed with asthma. The majority of these (9 patients) had 
Table I. Summary of findings of HIV infection given as number of patients in each category (N=50 (%))
     SPT            Family history
    N (%)  positive            of atopy  Asthma                Rhinitis            Eczema
WHO HIV
clinical stage
1   17 (34)  1 (2)  2 (4)      2 (4)  13 (26)             14 (28)
2   16 (32)  1 (2)  5 (10)      3 (6)    8 (16)               9 (18)
3   14 (28)  2 (4)  3 (6)      4 (16)    8 (16)               9 (18)
4     3 (6)  1 (2)  2 (4)      2 (4)    1 (2)                 2 (4)
CDC immunological stage 
CD4 count*
<15%     16 (32)  2 (4)  5 (10)      6 (12)    9 (18)             13 (26)
15 - 24%   21 (42)  2 (4)  5 (10)      3 (6)  15 (30)             15 (30)
>25%    13 (26)  1 (2)  2 (4)      2 (4)    6 (12)               6 (12)
*Centers for Disease control staging: <15% (stage 3), 15 - 24% (stage 2), >25% (stage 1). 
SPT = skin prick test.
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a negative SPT. Two of the asthmatic patients were WHO HIV 
stage 1, and only one of them had a positive SPT.
Of the 12 HIV-infected patients who had a family history 
of atopy, 8 (66.6%) gave a positive history of ‘allergic’ rhinitis. 
Thirty HIV-infected children (60%) gave a positive history of 
allergic rhinitis. All 5 patients who had a positive SPT had 
allergic rhinitis. Of the children with no family history of atopy, 
3 had positive SPTs; this constituted the majority of the total 
group (60%) with a positive SPT.
Thirty-four (68%) of the HIV-infected group had dermatitis. 
Of these, 10 had a family history of atopy and 10 had asthma. 
There was no relationship between CD4 count and SPT 
positivity, Welch t-test (p=0.61), logarithmic transformed CD4, 
and reported presence of  asthma (p=0.71) (95% confidence 
interval (Cl): -0.472 - 0.674), and log CD4 and reported presence 
of dermatitis (p=0.84) (95% CI: -0.556 - 0.457). There was also 
no relationship between CD4 count and family history of atopy 
(p=0.63) (95% CI: -0.329 - 0.532) (Table I).
The comparison between family history of atopy and log 
CD4 count was subject to the Welch two-sample t-test with 
unequal variances, with no correlation demonstrated (p=0.68) 
(Fig. 2). Group A (positive family history) and group B 
(negative family history) did not differ significantly (p=0.63) 
with regard to log CD4 counts, with mean log transformed 
CD4 counts 6.385 (95% CI 6.017 - 6.0753) and 6.487 (95% CI 
6.229 - 6.745), respectively. Twenty-eight (56%) of the total 
HIV-infected group had a CD4 <20%; 17 (35%) of these were 
WHO clinical stage 3 or 4. Seventeen (34%) were HIV stage 1; 
of these, only 2 had a family history of atopy. Only 1 of these 
children had a positive SPT.
Discussion
This pilot study suggests that there is no significant association 
between atopy and HIV-related disease, with no difference in 
allergy SPT positivity between HIV-infected children and a 
control group of healthy children. It also appears that the stage 
of HIV disease in HIV-infected children does not influence the 
development of allergy, which may be because the immune 
mechanisms are truly different. This is consistent with the 
findings by Bowser et al. in perinatally HIV-infected children.14
Ninety per cent of the HIV-infected children had negative 
SPTs to environmental allergens, demonstrating the absence 
of antigen-specific IgE to the measured allergens. Ten per cent 
of the HIV-infected children, who had evidence of atopy and 
a reactive SPT, probably have an inherent but independent 
genetic predisposition to atopy. In a study by Bacot et al., SPTs 
were positive in 28% of HIV-infected children, although adult 
studies report an incidence of around 10%.6 Interestingly, the 
most common aeroallergen in this study was D. pteronyssinus, 
which has been found to be present in 45% of asthmatics in 
Johannesburg.15
The pathogenesis of eczema is thought to be related to 
allergen uptake by the Langerhans cells in the skin via specific 
IgE bound to the high-affinity IgE receptors on cell surfaces, 
resulting in an allergen-specific T-cell response in memory CD4 
cells. It is well known that HIV-infected patients have a higher 
incidence of dermatitis;16 this may present as inflammatory 
or eczematous eruptions. Patients with HIV have dry skins, 
and this barrier disruption has been postulated by Rudikoff 
to favour a Th2-mediated response to exogenous allergens.16 
Bacot et al. found no correlation between the presence of atopic 
dermatitis and the level of immunosuppression in CD4 levels.6 
Our study confirmed this finding.
Adult studies have, however, demonstrated chronic pruritic 
or eczema rashes occurring much more frequently with more 
Table II. Summary of HIV-negative subjects (N=50 (%))
Number of positive SPTs   8 (16)
One aeroallergen    3 (6)
Two aeroallergens    2 (4)
Three or more aeroallergens   3 (6)
SPT = skin prick test.
Fig. 1. Graphic presentation of specific positive skin prick tests in HIV-infected and non-infected
children.
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severe HIV disease with CD4 counts <200/dl.17 HIV-infected 
patients may display inflammatory or erythematous rashes, 
including HIV eosinophilic folliculitis, papular urticaria, 
seborrhoeic dermatitis, psoriasis and pruritus nodularis, which 
resemble atopic dermatitis. This makes the distinction between 
atopic and non-atopic dermatitis difficult, particularly pruritus 
nodularis, which has a pruritic component.16 The presence of 
dermatitis in our study population was quite striking. Whether 
or not all these patients had eczema is difficult to delineate. All 
patients with a reactive SPT also had dermatitis. It therefore 
seems reasonable to suppose that a fair number of them were 
truly atopic. Other causes of dermatitis should also be included 
in a differential diagnosis, especially drug-related eruptions.
Sinusitis and ear infections are more common and are 
associated with hay fever and chronic nasal symptoms. The 
incidence of allergic rhinitis has been reported to be 20.7% in 
South Africa.17 There is a higher prevalence of rhinosinusitis 
related to a decrease in cellular immunity but unrelated to 
IgE-mediated hypersensitivity. Most patients in our group had 
house dust mite allergy. Evidence of causality of rhinitis in 
patients is complex, as most cases of rhinitis may be the result 
of an infection.18
The dermatitis and chronic rhinitis prevalent in these 
individuals is probably due to some other factor, such as 
infective processes or a dysfunctional immune system. 
Although there is a suggestion of differences in mean CD4 
counts between HIV-infected individuals, with and without a 
family history of atopy, it is not statistically significant, with 
overlapping 95% CIs. This measure of atopy is not related to 
HIV infection.
In the International Study of Asthma and Allergy in 
Childhood (ISAAC), South Africa reported on asthma 
prevalence of 13.6% in 13 - 14-year-old children in Cape 
Town.19 In the current study, 22% of patients were diagnosed 
with asthma, suggesting a higher prevalence in HIV-infected 
children. However, the possibility of chronic lung disease 
with airway reversibility may be contributing to the higher 
percentage. The absence of objective lung function testing is a 
weakness of the study. The reasonable correlation of CD4 count 
with HIV stage is an expected finding, as the CD4 count forms 
part of this assessment.
Many studies define atopy on the basis of elevation of IgE. In 
South African children, the burden of parasitic infection is high. 
One previous study demonstrated a 44% Ascaris lumbricoides 
positivity in the stool of children.20 Therefore, a total IgE level 
in this context becomes unreliable. In a study by Koutsonikolis 
et al., HIV-infected children had a higher total but not specific 
IgE.21
Our study has several limitations. No attempt was made to 
assess whether reported rhinitis in patients was truly allergic 
via Hansel staining. No CAP RAST testing was conducted for 
inhaled or food allergens. Because of the limitations of using 
a total IgE in our context where parasitic infection accounts 
for elevated levels, this was not tested. This study should be 
regarded as a pilot study of the important association between 
two extremely common disease states in South Africa. Both 
conditions are currently experiencing a rising prevalence in 
the country, and it is logical to assume that they will co-exist in 
some individuals.
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